Literature DB >> 25995039

Differential Immune Responses and Protective Effects in Avirulent Mycobacterial Strains Vaccinated BALB/c Mice.

Laicheng Liu1, Ruiling Fu, Xuefeng Yuan, Chunwei Shi, Shuling Wang, Xianyu Lu, Zhao Ma, Xiaoming Zhang, Weiyan Qin, Xionglin Fan.   

Abstract

Screening live mycobacterial vaccine candidates is the important strategy to develop new vaccines against adult tuberculosis (TB). In this study, the immunogenicity and protective efficacy of several avirulent mycobacterial strains including Mycobacterium smegmatis, M. vaccae, M. terrae, M. phlei, M. trivial, and M. tuberculosis H37Ra were compared with M. bovis BCG in BALB/c mice. Our results demonstrated that differential immune responses were induced in different mycobacterial species vaccinated mice. As BCG-vaccinated mice did, M. terrae immunization resulted in Th1-type responses in the lung, as well as splenocytes secreting IFN-γ against a highly conserved mycobacterial antigen Ag85A. M. smegmatis also induced the same splenocytes secreting IFN-γ as BCG and M. terrae did. In addition, M. terrae and M. smegmatis-immunized mice predominantly increased expression of IL-10 and TGF-β in the lung. Most importantly, mice vaccinated with H37Ra and M. vaccae could provide the same protection in the lung against virulent M. tuberculosis challenge as BCG. The result may have important implications in developing adult TB vaccine.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25995039     DOI: 10.1007/s00284-015-0837-3

Source DB:  PubMed          Journal:  Curr Microbiol        ISSN: 0343-8651            Impact factor:   2.188


  37 in total

Review 1.  The rapidly growing mycobacteria: saprophytes and parasites.

Authors:  S T Howard; T F Byrd
Journal:  Microbes Infect       Date:  2000-12       Impact factor: 2.700

2.  Increased frequency of CD4(+)CD25(high) Treg cells inhibit BCG-specific induction of IFN-gamma by CD4(+) T cells from TB patients.

Authors:  Li Li; Sui-Hua Lao; Chang-You Wu
Journal:  Tuberculosis (Edinb)       Date:  2007-09-11       Impact factor: 3.131

3.  [The immunotherapeutic effect of Mycobacterium vaccae vaccine on initially treated pulmonary tuberculosis].

Authors:  Y Luo
Journal:  Zhonghua Jie He He Hu Xi Za Zhi       Date:  2001-01

4.  Poor immunogenicity of BCG in helminth infected population is associated with increased in vitro TGF-beta production.

Authors:  Daniel Elias; Sven Britton; Abraham Aseffa; Howard Engers; Hannah Akuffo
Journal:  Vaccine       Date:  2008-05-21       Impact factor: 3.641

5.  Failure of the Mycobacterium bovis BCG vaccine: some species of environmental mycobacteria block multiplication of BCG and induction of protective immunity to tuberculosis.

Authors:  Lise Brandt; Joana Feino Cunha; Anja Weinreich Olsen; Ben Chilima; Penny Hirsch; Rui Appelberg; Peter Andersen
Journal:  Infect Immun       Date:  2002-02       Impact factor: 3.441

6.  Effects of infection with atypical mycobacteria on BCG vaccination and tuberculosis.

Authors:  C E Palmer; M W Long
Journal:  Am Rev Respir Dis       Date:  1966-10

7.  An essential role for phoP in Mycobacterium tuberculosis virulence.

Authors:  E Pérez; S Samper; Y Bordas; C Guilhot; B Gicquel; C Martín
Journal:  Mol Microbiol       Date:  2001-07       Impact factor: 3.501

8.  A recombinant Mycobacterium smegmatis induces potent bactericidal immunity against Mycobacterium tuberculosis.

Authors:  Kari A Sweeney; Dee N Dao; Michael F Goldberg; Tsungda Hsu; Manjunatha M Venkataswamy; Marcela Henao-Tamayo; Diane Ordway; Rani S Sellers; Paras Jain; Bing Chen; Mei Chen; John Kim; Regy Lukose; John Chan; Ian M Orme; Steven A Porcelli; William R Jacobs
Journal:  Nat Med       Date:  2011-09-04       Impact factor: 53.440

9.  Complete genome sequence of Mycobacterium vaccae type strain ATCC 25954.

Authors:  Yung S Ho; Sabir A Adroub; Maram Abadi; Bader Al Alwan; Reham Alkhateeb; Ge Gao; Alaa Ragab; Shahjahan Ali; Dick van Soolingen; Wilbert Bitter; Arnab Pain; Abdallah M Abdallah
Journal:  J Bacteriol       Date:  2012-11       Impact factor: 3.490

10.  Regulatory T cells depress immune responses to protective antigens in active tuberculosis.

Authors:  Jean-Michel Hougardy; Sammy Place; Marc Hildebrand; Annie Drowart; Anne-Sophie Debrie; Camille Locht; Francoise Mascart
Journal:  Am J Respir Crit Care Med       Date:  2007-05-31       Impact factor: 21.405

View more
  3 in total

1.  The Type of Growth Medium Affects the Presence of a Mycobacterial Capsule and Is Associated With Differences in Protective Efficacy of BCG Vaccination Against Mycobacterium tuberculosis.

Authors:  Rafael Prados-Rosales; Leandro J Carreño; Brian Weinrick; Ana Batista-Gonzalez; Aarona Glatman-Freedman; Jiayong Xu; John Chan; William R Jacobs; Steven A Porcelli; Arturo Casadevall
Journal:  J Infect Dis       Date:  2016-04-18       Impact factor: 5.226

2.  c-di-AMP Accumulation Regulates Growth, Metabolism, and Immunogenicity of Mycobacterium smegmatis.

Authors:  Huanhuan Ning; Xuan Liang; Yanling Xie; Lu Bai; Wei Zhang; Lifei Wang; Jian Kang; Yanzhi Lu; Yanling Ma; Guangchun Bai; Yinlan Bai
Journal:  Front Microbiol       Date:  2022-05-24       Impact factor: 6.064

3.  A New Adjuvant MTOM Mediates Mycobacterium tuberculosis Subunit Vaccine to Enhance Th1-Type T Cell Immune Responses and IL-2+ T Cells.

Authors:  Qi Yu; Xiaochun Wang; Xionglin Fan
Journal:  Front Immunol       Date:  2017-05-18       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.